Skip to main content
. 2022 May 25;9(4):1193–1201. doi: 10.1007/s40744-022-00461-w
Difficult-to-treat (D2T) is a new concept to define patients with persistence of symptoms and/or signs despite failure of multiple drugs.
The EULAR task force recently published the D2T criteria for patients with rheumatoid arthritis, however, a shared definition of D2T patient in PsA is still lacking.
Our study firstly evaluated the presence of clinical characteristics of potential D2T PsA patients by applying modified D2T criteria.
The presence of fibromyalgia, higher BMI, and comorbidities were associated with potential D2T PsA patients.